免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Liver Transplant CGM

NCT:NCT07216508 · ENROLLING_BY_INVITATION

NCT IDNCT07216508
狀態ENROLLING_BY_INVITATION
開始日期2025-10-13
完成時間2027-12-30
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

簡要摘要

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑